SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer
Clinical trial NCT03386162 · TERMINATED
Trial details
- NCT number
- NCT03386162
- Sponsor
- UNICANCER
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2022-11-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.